BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32729075)

  • 21. Computational Detection of Plant RNA Editing Events.
    Edera AA; Sanchez-Puerta MV
    Methods Mol Biol; 2021; 2181():13-34. PubMed ID: 32729072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbits.
    Jolivet G; Braud S; DaSilva B; Passet B; Harscoët E; Viglietta C; Gautier T; Lagrost L; Daniel-Carlier N; Houdebine LM; Harosh I
    PLoS One; 2014; 9(9):e106655. PubMed ID: 25216115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of apolipoprotein B mRNA editing enzyme (APOBEC1). structure-function relationships of RNA editing and dimerization.
    Teng BB; Ochsner S; Zhang Q; Soman KV; Lau PP; Chan L
    J Lipid Res; 1999 Apr; 40(4):623-35. PubMed ID: 10191286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors.
    Grünewald J; Zhou R; Garcia SP; Iyer S; Lareau CA; Aryee MJ; Joung JK
    Nature; 2019 May; 569(7756):433-437. PubMed ID: 30995674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein B messenger RNA editing: an update.
    Chan L
    Biochimie; 1995; 77(1-2):75-8. PubMed ID: 7599279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse APOBEC1 cytidine deaminase can induce somatic mutations in chromosomal DNA.
    Caval V; Jiao W; Berry N; Khalfi P; Pitré E; Thiers V; Vartanian JP; Wain-Hobson S; Suspène R
    BMC Genomics; 2019 Nov; 20(1):858. PubMed ID: 31726973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
    Rayon-Estrada V; Harjanto D; Hamilton CE; Berchiche YA; Gantman EC; Sakmar TP; Bulloch K; Gagnidze K; Harroch S; McEwen BS; Papavasiliou FN
    Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13296-13301. PubMed ID: 29167373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo.
    Petit V; Guétard D; Renard M; Keriel A; Sitbon M; Wain-Hobson S; Vartanian JP
    J Mol Biol; 2009 Jan; 385(1):65-78. PubMed ID: 18983852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying mRNA editing deaminase targets by RNA-Seq.
    Rosenberg BR; Dewell S; Papavasiliou FN
    Methods Mol Biol; 2011; 718():103-19. PubMed ID: 21370044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA binding to APOBEC deaminases; Not simply a substrate for C to U editing.
    Smith HC
    RNA Biol; 2017 Sep; 14(9):1153-1165. PubMed ID: 27869537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apobec-1 and apolipoprotein B mRNA editing.
    Chan L; Chang BH; Nakamuta M; Li WH; Smith LC
    Biochim Biophys Acta; 1997 Mar; 1345(1):11-26. PubMed ID: 9084497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific modification of gld-2 mRNA in C. elegans: likely C-to-U editing.
    Wang L; Kimble J; Wickens M
    RNA; 2004 Sep; 10(9):1444-8. PubMed ID: 15317977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.
    Chester A; Weinreb V; Carter CW; Navaratnam N
    RNA; 2004 Sep; 10(9):1399-411. PubMed ID: 15273326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism.
    Morrison JR; Pászty C; Stevens ME; Hughes SD; Forte T; Scott J; Rubin EM
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7154-9. PubMed ID: 8692961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific creation of uridine from cytidine in apolipoprotein B mRNA editing.
    Hodges PE; Navaratnam N; Greeve JC; Scott J
    Nucleic Acids Res; 1991 Mar; 19(6):1197-201. PubMed ID: 2030940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
    J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.